Literature DB >> 5661773

Hydrolysis of succinyldicholine and succinylmonocholine in human serum.

H W Goedde, K R Held, K Altland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5661773

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  8 in total

1.  The use of serum cholinesterase in succinylcholine apnoea.

Authors:  K L Scholler; H W Goedde; H G Benkmann
Journal:  Can Anaesth Soc J       Date:  1977-05

2.  Clinical pharmacokinetics of muscle relaxants.

Authors:  L B Wingard; D R Cook
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

3.  Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.

Authors:  M C McGuire; C P Nogueira; C F Bartels; H Lightstone; A Hajra; A F Van der Spek; O Lockridge; B N La Du
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Degradation and elimination of succinylcholine and succinylmonocholine and definition of their respective detection windows in blood and urine for forensic purposes.

Authors:  Uta Kuepper; Frank Herbstreit; Jürgen Peters; Burkhard Madea; Frank Musshoff
Journal:  Int J Legal Med       Date:  2011-09-24       Impact factor: 2.686

5.  Immunological comparison of the usual and atypical human serum cholinesterase phenotypes.

Authors:  H W Eckerson; A Oseroff; O Lockridge; B N La Du
Journal:  Biochem Genet       Date:  1983-02       Impact factor: 1.890

6.  Heterogeneity in the silent gene phenotype of psudocholinesterase of human serum.

Authors:  K Altland; H W Goedde
Journal:  Biochem Genet       Date:  1970-04       Impact factor: 1.890

7.  A note on suxamethonium sensitivity and serum cholinesterase variants.

Authors:  D P Agarwal; L M Srivastava; H W Goedde
Journal:  Hum Genet       Date:  1976-04-15       Impact factor: 4.132

8.  Structural difference at the active site of dibucaine resistant variant of human plasma cholinesterase.

Authors:  H Muensch; A Yoshida; K Altland; W Jensen; H W Goedde
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.